Connor, Clark & Lunn Investment Management (CC&L)
RGNX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Regenxbio RGNX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RGNX Stock Details RGNX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$714K Buy
2025
Q1 		– Sell
2024
Q4 		$104K Sell
2024
Q3 		$643K Buy
2022
Q2 		– Sell
2022
Q1 		$1.49M Sell
2021
Q4 		$2.15M Sell
2021
Q3 		$3.23M Buy
2018
Q4 		– Sell
2018
Q3 		$579K Buy